The Prevent Coronary Artery Disease Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1600 participants.
Also called NCT06494501
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 1,600 participants
- Registry
-
NCT06494501
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06494501. Randomized; no masking; primary purpose prevention. Start 2024-09-12 (actual); primary completion 2032-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Prevent Coronary Artery Disease Trial
- Acronym
- PRECAD
- Condition
- Atherosclerotic Cardiovascular Disease
- Intervention (Drug)
- Inclisiran
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
Record details
- Record id
cardio:ct-nct06494501- Content hash
2d1fb2fae699afe5062fa4dcd167f813eeea7c845befdd2b82447795a5a8a25a